Cerebrolysin
Cerebrolysin is a protein-based agent that exhibits unique neurotrophic (assisting growth) and neuroprotective activity. It has been studied in thousands of patients in double-blind studies with consistently excellent results.
Some of the effects include:
Protects nerve cells from damage
Decreases damage from excitotoxic effects
Blocks over activity of calcium dependent proteases (this reduces spasm)
It scavenges free Oxygen radicals
It increases nerve viability and survival during and after ischemic events (lack of oxygen)
Slows progressive global and cognitive decline (helps prevent mental decline)
As these effects are widespread, Cerebrolysin can be used for a large number of conditions. These include:
Any organic, neurologic, and degenerative disorders of the brain
Alzheimer’s and dementia
Neurological trauma of any type
Any conditions with low oxygen as a component
Cerebrolysin can be used either for acute stroke or later for rehabilitation. When used for dementia/Alzheimer’s, it is able to stop the progression of the disease and also improve the current symptoms. Cerebrolysin is given via intravenous infusion, unless a very small dose is used. It is administered one time per day, five times per week, for a total of 20 treatments. The treatment is then stopped for 4 weeks, after which the cycle can repeat as often as needed.
No safety concerns were noted during clinical trials. Side effects were rare, and at the same frequency in groups getting the active agent or the placebo. The most common events were vertigo, agitation, and feeling hot, all of which were mild and short-lived.
In summary, Cerebrolysin is a safe, effective therapy that can be used for nearly any problem involving the brain.